The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
Fidelity MSCI Health Care ETF FHLC
Morningstar’s Analysis FHLC
Will FHLC outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 50.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 11.14 | 330.2 Mil | Healthcare |
UnitedHealth Group Inc | 8.44 | 250.0 Mil | Healthcare |
Johnson & Johnson | 6.00 | 177.9 Mil | Healthcare |
AbbVie Inc | 5.38 | 159.4 Mil | Healthcare |
Merck & Co Inc | 4.39 | 130.2 Mil | Healthcare |
Thermo Fisher Scientific Inc | 3.62 | 107.3 Mil | Healthcare |
Abbott Laboratories | 3.06 | 90.7 Mil | Healthcare |
Danaher Corp | 2.83 | 83.7 Mil | Healthcare |
Intuitive Surgical Inc | 2.67 | 79.2 Mil | Healthcare |
Amgen Inc | 2.65 | 78.7 Mil | Healthcare |